Analysis Metabolite Name Measured Value Units Sex Severity_Scale Race Ethnicity hasSmokingBeforeCOVID-19 Time
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 0 Black Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 0 Black Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 0 Black Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 0 Black Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 0 Other Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 0 Other Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 0 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 0 Other Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 0 Other Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 0 Other Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 0 White Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 1 Black Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 1 Black Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 1 Black Non-Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 1 Black Non-Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 1 Other Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 1 Other Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 1 Other Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 1 White Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 1 White Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 1 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 1 White Non-Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 1 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 2 Black Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 2 Black Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 2 Black Non-Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 2 Other Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 2 Other Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 2 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 2 Other Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 2 White Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 2 White Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 2 White Non-Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 2 White Non-Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 2 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 3 Black Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 3 Black Non-Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 3 Black Non-Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 3 White Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataFemale 3 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 0 Black Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 0 Black Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 0 Other Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 0 Other Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 0 White Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 0 White Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 0 White Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 0 White Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 0 White Non-Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 Black Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 Black Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 Black Non-Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 Black Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 Other Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 Other Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 Other Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 Other Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 Other Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 White Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 White Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 White Non-Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 1 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 2 Black Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 2 White Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 2 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 2 White Non-Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 2 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 3 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 3 Other Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 3 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 3 White Non-Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.448539128log transformed dataMale 3 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.42085893log transformed dataFemale 3 Other Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.346038194log transformed dataFemale 1 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.336281187log transformed dataFemale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.331562294log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.326093786log transformed dataMale 1 Black Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.323474735log transformed dataMale 1 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.319412301log transformed dataFemale 0 White Non-Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.303584709log transformed dataMale 3 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.299486336log transformed dataMale 3 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.294469253log transformed dataFemale 1 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.279018267log transformed dataFemale 3 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.273717218log transformed dataFemale 0 White Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.266460321log transformed dataMale 0 Black Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.260551465log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.259745105log transformed dataFemale 0 Black Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.258515226log transformed dataFemale 0 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.257789149log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.257067026log transformed dataMale 3 White Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.253042172log transformed dataMale 0 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.252436664log transformed dataFemale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.248942145log transformed dataMale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.247972672log transformed dataFemale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.241862585log transformed dataFemale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.228378816log transformed dataFemale 3 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.219887578log transformed dataFemale 2 Black Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.218445844log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.216159355log transformed dataMale 1 White Non-Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.210513852log transformed dataMale 1 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.210046281log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.208993188log transformed dataFemale 1 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.206866729log transformed dataMale 3 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.199816662log transformed dataMale 1 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.199311147log transformed dataFemale 1 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.199139182log transformed dataFemale 1 White Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.199096937log transformed dataMale 0 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.198988857log transformed dataFemale 1 White Non-Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.193524276log transformed dataFemale 1 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.186997107log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.183138772log transformed dataFemale 1 Black Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.182410278log transformed dataFemale 0 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.181034676log transformed dataFemale 0 Black Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.178647624log transformed dataMale 3 Other Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.171606954log transformed dataFemale 0 White Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.171147059log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.167734918log transformed dataMale 0 White Non-Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.166057722log transformed dataFemale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.165795212log transformed dataFemale 1 Other Non-Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.164541061log transformed dataFemale 1 White Non-Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.157113553log transformed dataMale 0 Black Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.156534829log transformed dataMale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.156112795log transformed dataFemale 0 White Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.150857784log transformed dataMale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.149404794log transformed dataFemale 1 Other Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.146552344log transformed dataMale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.146191402log transformed dataMale 1 White Non-Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.142138427log transformed dataMale 0 Black Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.137402014log transformed dataFemale 0 White Non-Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.133353781log transformed dataFemale 1 Black Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.131348159log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.130529727log transformed dataFemale 1 Black Non-Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.12817109log transformed dataFemale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.126628347log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.126622644log transformed dataMale 1 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.124976299log transformed dataMale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.124829151log transformed dataMale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.123985556log transformed dataFemale 0 White Non-Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.12327611log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.120309928log transformed dataMale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.119559228log transformed dataFemale 1 Other Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.118373742log transformed dataFemale 1 Other Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.112540044log transformed dataFemale 0 White Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.112202801log transformed dataFemale 1 Black Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.111873587log transformed dataFemale 0 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.10977137log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.109489137log transformed dataMale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.109206924log transformed dataMale 2 Black Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.103954749log transformed dataMale 2 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.102930299log transformed dataFemale 2 Black Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.100814915log transformed dataFemale 0 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.099838489log transformed dataMale 3 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.095494154log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.091140158log transformed dataFemale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.090556591log transformed dataFemale 0 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.090525754log transformed dataMale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.08922186log transformed dataMale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.084061541log transformed dataFemale 0 Other Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.082811884log transformed dataFemale 0 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.076550594log transformed dataFemale 0 Other Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.075347864log transformed dataMale 0 Other Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.072085947log transformed dataFemale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.071668717log transformed dataFemale 0 Other Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.071456951log transformed dataMale 1 Other Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.071434482log transformed dataMale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.069801799log transformed dataMale 0 Black Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.064936037log transformed dataMale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.063817171log transformed dataFemale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.056974469log transformed dataMale 2 Other Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.055797217log transformed dataFemale 0 Other Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.055396381log transformed dataFemale 0 Other Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.054737084log transformed dataMale 0 Other Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.050856601log transformed dataMale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.049648048log transformed dataFemale 1 Black Non-Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.048610257log transformed dataFemale 0 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.04612383log transformed dataMale 2 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.044162803log transformed dataMale 0 White Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.039268745log transformed dataFemale 3 White Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.036826039log transformed dataFemale 0 Other Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.036607781log transformed dataMale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.034896069log transformed dataMale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.033960679log transformed dataMale 0 White Non-Hispanic 1 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.032255275log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.031455234log transformed dataMale 2 White Non-Hispanic 0 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.031171573log transformed dataMale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.03062961log transformed dataFemale 1 Other Hispanic 1 during COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.0291261log transformed dataFemale 2 White Non-Hispanic 1 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.028306269log transformed dataFemale 0 Other Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.028291947log transformed dataMale 0 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.025464791log transformed dataFemale 0 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.023307838log transformed dataFemale 0 Other Non-Hispanic 0 post-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.022201119log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.022139393log transformed dataFemale 2 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.02179463log transformed dataFemale 0 Other Hispanic 0 pre-COVID-19
Reversed phase NEGATIVE ION MODE2-arachidonoylglycerol (20:4)-0.020260721log transformed dataFemale 0 White Non-Hispanic 0 pre-COVID-19

Return to search page
  logo